drugset / Trial / NCT01391715

Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD

NCT01391715 ↗

Phase 3 Withdrawn Inje University
RandomizedParallel-groupOpen-labelTreatment

Summary

To the best of our knowledge, there has been no randomized controlled trial to compare double dose PPI therapy with standard one dose PPI therapy for NERD patients. Thus, we hypothesize that a double dose PPI would accelerate and sustain the control of symptom in NERD patients.

Timeline

Start
2011-08
Primary completion
2012-10
Completion
2012-12

Outcome

Outcome not reported

Stopped: “patients could not be recuited within study duration”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rabeprazole Small molecule 20 mg —